Growth differentiation factor-15, high-sensitivity cardiac troponin T, and N-terminal pro-B-type natriuretic peptide for predicting risk of venous thromboembolism in ambulatory cancer patients receiving chemotherapy - Roy, D C; Wang, T-F; Mallick, R (Thromb Haemost, 2022)